Recorded Sessions (Not accredited)
- Session 1: Rapid Diagnosis, Risk Stratification, and Induction Therapies
- Session 2: Evolving Treatment in Cell Therapy and Transplant
- Session 3: Coordinated Care from Treatment to Survivorship
Description
The Project ECHO model is designed to create a shared learning space for healthcare professionals through a series of educational sessions, fostering peer engagement and disseminating best practices in community care. Rapid advances in the treatment of acute leukemias, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), can make treatment decisions challenging. This virtual series will help providers stay up to date on the latest in disease-specific indications, treatment with HCT and cell therapy, and post-treatment monitoring and care coordination to improve patient outcomes.
Target Audience
This activity is intended for hematology-oncology providers, including physicians, APPs and nurses who want to learn more about managing, treating, and monitoring patients with acute leukemias including those undergoing transplant and cell therapy.
Learning Objectives
After completing this activity, the participant should be better able to:
Session 1:
- Describe disease-specific features and indications of acute leukemias, including subtype classification
- Identify tests used to diagnose acute leukemias
- Examine therapeutic options for induction
Session 2:
- Examine the appropriate treatments for acute leukemias and timing, including allogeneic HCT and CAR T-cell therapy
- Identify and manage treatment related side effects and treatment related complications
Session 3
- Discuss post-treatment monitoring of long-term and late effects and surveillance strategies for detecting relapse post allogeneic HCT and CAR T-cell therapy
- Identify best practices in care coordination between hematology-oncology, transplant, and otherproviders involved in the care of patients
Faculty
Chairs/moderators, all sessions:
Alison Loren, MD, MSCE
Chief, Division of Hematology/Oncology
Director, Blood and Marrow Transplantation
C. Willard Robinson Professor of Hematology/Oncology
University of Pennsylvania
Philadelphia, PA
Shernan Holtan, MD
Chief, Blood and Marrow Transplantation Section
Department of Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, NY
Session 1:
Alice S. Mims, MD, MSCR
Acute Leukemia Research Section Head
Associate Division Director Clinical Research
Professor of Medicine
The Ohio State University Comprehensive Cancer Center
Columbus, OH
Courtney Bellomo, MD
Director of Stem Cell Therapy
Hematology CAR-T Lead
New York Oncology Hematology
Albany, NY
Meghan McGrath, MSN, RN, AGACNP-BC
Clinical Trial Nurse Navigator
Blood Cancer United
Washington, DC
Session 2:
Clark Alsfeld, MD
Attending Physician
Ochsner MD Anderson Cancer Center
Ochsner Health
New Orleans, LA
Alice S. Mims, MD, MSCR
Acute Leukemia Research Section Head
Associate Division Director Clinical Research
Professor of Medicine
The Ohio State University Comprehensive Cancer Center
Columbus, OH
Darci Zblewski, APN, C-NP
Consultant
Blood Cancer United
Washington, DC
Session 3:
Clark Alsfeld, MD
Attending Physician
Ochsner MD Anderson Cancer Center
Ochsner Health
New Orleans, LA
Courtney Bellomo, MD
Director of Stem Cell Therapy
Hematology CAR-T Lead
New York Oncology Hematology
Albany, NY
Ankita Shah, FNP-BC
Access Partnership Consultant
NMDP
Minneapolis, MN
Providers
This activity is provided by Blood Cancer United and NMDP, in collaboration with Project ECHO.
There is no commercial support for this activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: [email protected].